Vascular Disease and Surgery


Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Related Articles


The Role of Mental Stress in INOCA and Coronary Vasomotor Disorders

Roos ET van der Meer, Angela Maas,


Citation: European Cardiology Review 2021;16:e37.

TAVI in Challenging Scenarios

Sandra Santos-Martínez, Ignacio J Amat-Santos,


Citation: European Cardiology Review 2021;16:e29.

Pharmacotherapy in Stable CAD: The ISCHEMIA Trial

Jonathan Yap, Derek P Chew, Gregg Stone,


Citation: European Cardiology Review 2021;16:e04.

Interatrial Shunting for Left Heart Failure

Leonardo Guimaraes, David del Val, Sebastien Bergeron,


Citation: European Cardiology Review 2020;15:e18.